Pınar GÜNDOĞAN BOZDAĞ, Murat BAYKARA, Nevsun PIHTILI TAŞ

Muscle density analysis in COVID-19

Aim: Coronavirus-2019 (COVID-19) was declared a pandemic by the World Health Organization, continues to spread globally, and patients may not exhibit specific musculoskeletal involvement symptoms. Materials and Methods: Clinical data and images of 389 consecutive patients, who applied to the pandemic outpatient clinic with a COVID-19 pre-diagnosis with musculoskeletal complaints, and 203 consecutive control patients who underwent thoracic computed tomography (CT) for an unrelated reason and diagnosed as normal were included in the study. Bilateral sternocleidomastoid and trapezius muscle CT density and blood creatine kinase (CK) levels of all participants were obtained. Results: In COVID-19 patients, a significant decrease in sternocleidomastoid muscle density was observed when compared to radiological grade; however, a significant increase in the density of the trapezius muscle was identified. In CK values, there was a significant increase in trapezius density. Conclusion: Although the cause or effect was controversial, respiratory muscles were affected due to forced breathing and muscle damages were determined. This study demonstrated the need for multicenter studies with detailed neurological and electrophysiological tests and pathological correlations with an adequate number of patients.

PDF

___

1. Wu, Y.C., C.S. Chen, and Y.J. Chan, The outbreak of COVID- 19: An overview. J Chin Med Assoc, 2020. 83(3): p. 217-220.
2. Orskov, S., et al., The COVID-19 pandemic: Key considerations for the epidemic and its control. APMIS, 2021.
3. Altunisik Toplu, S., et al., Short-term experiences of a liver transplant centre before and after the COVID-19 pandemic. International Journal of Clinical Practice, 2021. 75(10): p. e14668.
4. Cummings, M.J., et al., Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study. Lancet, 2020. 395(10239): p. 1763- 1770.
5. Mao, L., et al., Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China. JAMA Neurol, 2020. 77(6): p. 683-690.
6. Lechien, J.R., et al., Clinical and epidemiological characteristics of 1420 European patients with mild-to-moderate coronavirus disease 2019. J Intern Med, 2020. 288(3): p. 335-344.
7. Li, Y., et al., The Psychological Symptoms of College Student in China during the Lockdown of COVID-19 Epidemic. Healthcare (Basel), 2021. 9(4).
8. Ferrandi, P.J., S.E. Alway, and J.S. Mohamed, Last Word on Viewpoint: The interaction between SARS-CoV-2 and ACE2 may have consequences for skeletal muscle viral susceptibility and myopathies. J Appl Physiol (1985), 2020. 129(4): p. 872.
9. Tan, A.L., et al., Commentaries on Viewpoint: The interaction between SARS-CoV-2 and ACE2 may have consequences for skeletal muscle viral susceptibility and myopathies. J Appl Physiol (1985), 2020. 129(4): p. 868-871.
10. Ferrandi, P.J., S.E. Alway, and J.S. Mohamed, The interaction between SARS-CoV-2 and ACE2 may have consequences for skeletal muscle viral susceptibility and myopathies. J Appl Physiol (1985), 2020. 129(4): p. 864-867.
11. Frantz, E.D.C., et al., Modulation of the renin-angiotensin system in white adipose tissue and skeletal muscle: focus on exercise training. Clin Sci (Lond), 2018. 132(14): p. 1487-1507.
12. Chen, T., et al., Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. BMJ, 2020. 368: p. m1091.
13. Yang, Y., et al., Comparative Sensitivity of Different Respiratory Specimen Types for Molecular Diagnosis and Monitoring of SARS-CoV-2 Shedding. Innovation (N Y), 2020. 1(3): p. 100061.
14. Prado, C.M., L.A. Birdsell, and V.E. Baracos, The emerging role of computerized tomography in assessing cancer cachexia. Curr Opin Support Palliat Care, 2009. 3(4): p. 269-75.
15. Chan, D.C., et al., Association between skeletal muscle fat content and very-low-density lipoprotein-apolipoprotein B-100 transport in obesity: effect of weight loss. Diabetes Obes Metab, 2014. 16(10): p. 994-1000.
16. Yamashita, M., et al., Low skeletal muscle density combined with muscle dysfunction predicts adverse events after adult cardiovascular surgery. Nutr Metab Cardiovasc Dis, 2021.
17. Kushlaf, H., COVID-19 in muscle-specific kinase myasthenia gravis: A case report. Muscle Nerve, 2020. 62(4): p. E65-E66.
18. Simpson, S., et al., Radiological Society of North America Expert Consensus Document on Reporting Chest CT Findings Related to COVID-19: Endorsed by the Society of Thoracic Radiology, the American College of Radiology, and RSNA. Radiology: Cardiothoracic Imaging, 2020. 2(2): p. e200152.
19. Ciotti, M., et al., COVID-19 Outbreak: An Overview. Chemotherapy, 2019. 64(5-6): p. 215-223.
20. Reina Ortiz, M., et al., Developing Global Health Diplomacyrelated Skills Using a COVID-19-like Epidemic Simulation as a Learning Strategy. Am J Trop Med Hyg, 2021.
21. Sahin, T.T., S. Akbulut, and S. Yilmaz, COVID-19 pandemic: Its impact on liver disease and liver transplantation.World Journal of Gastroenterology, 2020. 26(22): p. 2987.
22. Long, C., et al., Diagnosis of the Coronavirus disease (COVID- 19): rRT-PCR or CT? Eur J Radiol, 2020. 126: p. 108961.
23. Osman, A.A., M.M. Al Daajani, and A.J. Alsahafi, Re-positive coronavirus disease 2019 PCR test: could it be a reinfection? New Microbes New Infect, 2020. 37: p. 100748.
24. Lal, A., A.K. Mishra, and K.K. Sahu, CT chest findings in coronavirus disease-19 (COVID-19). J Formos Med Assoc, 2020. 119(5): p. 1000-1001.
25. Sahu, K.K., A. Lal, and A.K. Mishra, An update on CT chest findings in coronavirus disease-19 (COVID-19). Heart Lung, 2020. 49(5): p. 442-443.
26. Bernheim, A., et al., Chest CT Findings in Coronavirus Disease- 19 (COVID-19): Relationship to Duration of Infection. Radiology, 2020. 295(3): p. 200463.
27. Rona, G., et al., Should CT be used for the diagnosis of RT-PCRnegative suspected COVID-19 patients? Clin Respir J, 2021. 15(5): p. 491-498.
28. Kucuk, A., M. Cumhur Cure, and E. Cure, Can COVID-19 cause myalgia with a completely different mechanism? A hypothesis. Clin Rheumatol, 2020. 39(7): p. 2103-2104.
29. Hamming, I., et al., Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J Pathol, 2004. 203(2): p. 631-7.
30. Yamamoto, K., H. Takeshita, and H. Rakugi, ACE2, angiotensin 1-7 and skeletal muscle: review in the era of COVID-19. Clin Sci (Lond), 2020. 134(22): p. 3047-3062.
31. Harlaar, L., et al., Imaging of respiratory muscles in neuromuscular disease: A review. Neuromuscul Disord, 2018. 28(3): p. 246-256.
32. Hudson, A.L., S.C. Gandevia, and J.E. Butler, The effect of lung volume on the co-ordinated recruitment of scalene and sternomastoid muscles in humans. J Physiol, 2007. 584(Pt 1): p. 261-70.
33. Barreiro, E., et al., Oxidative stress and respiratory muscle dysfunction in severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med, 2005. 171(10): p. 1116-24.
34. Gransee, H.M., C.B. Mantilla, and G.C. Sieck, Respiratory muscle plasticity. Compr Physiol, 2012. 2(2): p. 1441-62.
35. van der Werf, A., et al., Skeletal muscle analyses: agreement between non-contrast and contrast CT scan measurements of skeletal muscle area and mean muscle attenuation. Clin Physiol Funct Imaging, 2018. 38(3): p. 366-372.
36. Magal, M., et al., Relationship between serum creatine kinase activity following exercise-induced muscle damage and muscle fibre composition. J Sports Sci, 2010. 28(3): p. 257-66.
37. Lilleng, H., et al., Variation of serum creatine kinase (CK) levels and prevalence of persistent hyperCKemia in a Norwegian normal population. The Tromso Study. Neuromuscul Disord, 2011. 21(7): p. 494-500.